PLIANT THERAPEUTICS, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2502c8e0-0de8-49ca-951f-31f86be637d2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-156.4M | 2025-01-01 – 2025-12-31 | evidence 0001746473-26-000037 |
| FY 2024 | $-228.4M | 2024-01-01 – 2024-12-31 | evidence 0001746473-25-000054 |
| FY 2023 | $-184.1M | 2023-01-01 – 2023-12-31 | evidence 0001746473-24-000043 |
| FY 2022 | $-127.2M | 2022-01-01 – 2022-12-31 | evidence 0001746473-23-000008 |
| FY 2021 | $-97.5M | 2021-01-01 – 2021-12-31 | evidence 0001746473-22-000010 |
| FY 2020 | $-41.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013589 |
| FY 2019 | $-1.2M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-013589 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PLIANT THERAPEUTICS, INC. — all facts · Revenue · Net Income